Shelter Pharma Limited has filed its quarterly compliance certificate under SEBI regulations for the quarter ended 31st March, 2026. The pharmaceutical company submitted the mandatory documentation to BSE Limited on 14th April, 2026, fulfilling its regulatory obligations under the Securities and Exchange Board of India framework.

Regulatory Compliance Details

The certificate was submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This regulation pertains to the dematerialisation and rematerialisation processes of securities held by public companies.

Certificate Findings

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the certificate on 06th April, 2026. The registrar confirmed that Regulation 74(5) is not applicable to Shelter Pharma Limited during the reporting quarter.

Key findings from the certificate include:

• The entire shareholding of the company remains in dematerialised form
• No requests for rematerialisation were received from shareholders during Q4FY26
• No requests for dematerialisation were processed during the quarter
• The company maintains full compliance with electronic shareholding requirements

Corporate Governance

The submission was authorised by Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited (DIN: 01456841). The documentation was digitally signed and submitted from the company's Ahmedabad office, demonstrating adherence to modern corporate governance practices.

This quarterly filing reflects the company's commitment to maintaining transparent regulatory compliance and ensuring proper documentation of its shareholding structure for investor protection and market integrity.

Shelter Pharma Limited has announced a strategic initiative to hire senior management personnel as part of its business expansion plans, according to a regulatory filing dated April 07, 2026. The company informed BSE Limited about this structured hiring process under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Hiring Initiative

The pharmaceutical company has initiated a comprehensive process to onboard experienced professionals in senior management roles. This move is strategically aligned with the company's expansion plans across domestic markets, demonstrating a focused approach to strengthening its organizational capabilities.

Key Leadership Positions

Shelter Pharma is actively identifying and evaluating suitable candidates for several critical positions:

Business Objectives

The hiring initiative serves multiple strategic objectives for the company's growth trajectory. The primary focus is to strengthen the management team structure while enhancing operational efficiency across various business functions. This approach is designed to support the company's long-term business growth ambitions in the pharmaceutical sector.

Regulatory Compliance

The announcement was made in full compliance with regulatory requirements, with Managing Director Mustaqim Nisarahmed Sabugar (DIN: 01456841) signing the disclosure document. The filing was digitally signed and submitted from the company's Ahmedabad office, ensuring transparency with stakeholders and regulatory authorities.

Market Expansion Focus

The structured hiring process reflects Shelter Pharma's commitment to expanding its presence in domestic markets. By bringing in experienced professionals for key leadership roles, the company aims to enhance its competitive position and operational capabilities in the pharmaceutical industry.